• Sentimag Gen Ad x
  • US KEY Keytruda ADT HCP Update Patient Candidate Banner Ads MT Branded Static x
  • Surgical Oncology Insight Banner Ad x

ADVERTISEMENT

Global Header

Annals of Surgical Oncology

HIGHLIGHTED ARTICLES FROM ANNALS OF SURGICAL ONCOLOGY

Weekly Update

A Randomized Phase III Trial of Complete Mesocolic Excision Compared with Conventional Surgery for Right Colon Cancer: Interim Analysis of a Nationwide Multicenter Study of the Italian Society of Surgical Oncology Colorectal Cancer Network (CoME-in trial)

March 28, 2024

Citation: Degiuli, M., Aguilar, A.H.R., Solej, M. et al. A Randomized Phase III Trial of Complete Mesocolic Excision Compared with Conventional Surgery for Right Colon Cancer: Interim Analysis of a Nationwide Multicenter Study of the Italian Society of Surgical Oncology Colorectal Cancer Network (CoME-in trial). Ann Surg Oncol 31, 1671–1680 (2024). https://doi.org/10.1245/s10434-023-14664-0
Synopsis: This report shows interim data of a multicenter randomized controlled trials comparing complete mesocolic excision (CME) vs right colectomy in patient with right colon cancer. After the enrollment of 258 patients, CME is documented to improve lymph node yield and quality of surgery, without increasing complications.

Outcomes of Neoadjuvant Chemotherapy for Invasive Intraductal Papillary Mucinous Neoplasm Compared with de Novo Pancreatic Adenocarcinoma

March 28, 2024

Citation: Fogliati, A., Zironda, A., Fiorentini, G. et al. Outcomes of Neoadjuvant Chemotherapy for Invasive Intraductal Papillary Mucinous Neoplasm Compared with de Novo Pancreatic Adenocarcinoma. Ann Surg Oncol 31, 2632–2639 (2024). https://doi.org/10.1245/s10434-023-14875-5 
Synopsis: This retrospective cohort study suggests that invasive intraductal papillary mucinous cystic neoplasms (IPMN) have a better prognosis when compared to de novo pancreatic ductal adenocarcinoma, and their response to neoadjuvant chemotherapy appears non-inferior.

Listen to the ASO's new podcast, Speaking of SurgOnc®

Speaking of SurgOnc Speaking of SurgOnc® is a podcast brought to you by the Annals of Surgical Oncology (ASO) and the Society of Surgical Oncology (SSO).

The series is hosted by ASO Deputy Editor Dr. Frederick L. (Rick) Greene, who will expand upon ideas from articles published in the Annals. Once a month, Dr. Greene will interview authors and leading experts in surgical oncology.

Listen to the podcast here.

ASO is the journal of choice of surgical oncologists and cancer multidisciplinary teams worldwide regarding surgical oncology research and education, and benefits surgeons, oncologists, hematologists, radiologists, general practitioners, pathologists, researchers, academicians, and other clinical professionals interested in all aspects of the surgical treatment of cancer. ASO strives to improve the practice environment in which high-quality surgical oncology care is delivered, to enhance the quality of life and survival of the surgical patient with cancer.

Join the conversation! Follow the journal on Twitter and Instagram. Help to expand the reach of the journal to support the research and practice needs of surgical oncologists and their patients.

twitter icon instagram icon

Scroll to Top